BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25186097)

  • 1. Folate depletion and increased glutamation in juvenile idiopathic arthritis patients treated with methotrexate.
    Funk RS; van Haandel L; Leeder JS; Becker ML
    Arthritis Rheumatol; 2014 Dec; 66(12):3476-85. PubMed ID: 25186097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell folate concentrations and polyglutamate distribution in juvenile arthritis: predictors of folate variability.
    Becker ML; van Haandel L; Gaedigk R; Thomas B; Hoeltzel MF; Lasky A; Dai H; Stobaugh J; Leeder JS
    Pharmacogenet Genomics; 2012 Apr; 22(4):236-46. PubMed ID: 22344247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: a pilot study.
    Huemer M; Födinger M; Huemer C; Sailer-Höck M; Falger J; Rettenbacher A; Bernecker M; Artacker G; Kenzian H; Lang T; Stöckler-Ipsiroglu S
    Clin Exp Rheumatol; 2003; 21(2):249-55. PubMed ID: 12747286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.
    Funk RS; Chan MA; Becker ML
    Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Caldwell J; Kremer J
    Ann Rheum Dis; 2005 Aug; 64(8):1180-5. PubMed ID: 15677700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse model.
    Singh RK; van Haandel L; Kiptoo P; Becker ML; Siahaan TJ; Funk RS
    Eur J Pharmacol; 2019 Jun; 853():264-274. PubMed ID: 30951714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis.
    Dervieux T; Greenstein N; Kremer J
    Arthritis Rheum; 2006 Oct; 54(10):3095-103. PubMed ID: 17009228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis.
    Gohar F; Anink J; Moncrieffe H; Van Suijlekom-Smit LWA; Prince FHM; van Rossum MAJ; Dolman KM; Hoppenreijs EPAH; Ten Cate R; Ursu S; Wedderburn LR; Horneff G; Frosch M; Foell D; Holzinger D
    J Rheumatol; 2018 Apr; 45(4):547-554. PubMed ID: 29335345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
    Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
    Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study.
    Hawwa AF; AlBawab A; Rooney M; Wedderburn LR; Beresford MW; McElnay JC
    Arthritis Res Ther; 2015 Oct; 17():295. PubMed ID: 26493320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients.
    Leeb BF; Witzmann G; Ogris E; Studnicka-Benke A; Andel I; Schweitzer H; Smolen JS
    Clin Exp Rheumatol; 1995; 13(4):459-63. PubMed ID: 7586777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
    Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay.
    Möhlmann JE; de Roock S; Egas AC; Weijden ET; Doeleman MJH; Huitema ADR; van Luin M; Swart JF
    Pediatr Rheumatol Online J; 2024 May; 22(1):52. PubMed ID: 38715014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of methotrexate in juvenile idiopathic arthritis.
    Ramanan AV; Whitworth P; Baildam EM
    Arch Dis Child; 2003 Mar; 88(3):197-200. PubMed ID: 12598376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.
    Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y
    Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
    Bulatović Ćalasan M; Vastert SJ; Scholman RC; Verweij F; Klein M; Wulffraat NM; Prakken BJ; van Wijk F
    Rheumatology (Oxford); 2015 Sep; 54(9):1724-34. PubMed ID: 25877908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
    Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis.
    Zajc Avramovič M; Dolžan V; Toplak N; Accetto M; Lusa L; Avčin T
    J Rheumatol; 2017 Aug; 44(8):1216-1223. PubMed ID: 28572465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methotrexate in the therapy of juvenile idiopathic arthritis].
    Holzinger D; Frosch M; Föll D
    Z Rheumatol; 2010 Aug; 69(6):496-504. PubMed ID: 20632181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.